“…Pregnancy is accompanied not only by increased immune activation (Anderson and Maes, 2013) and consequent TRYCAT pathway activation (Anderson and Maes, 2013), but also O & NS as indicated by increased lipid peroxides (Patil et al, 2006;Walsh, 1994), production of NO metabolites (NOx) (Choi et al, 2002) and AOPP levels (Fialová et al, 2003;Kalousová et al, 2002). Antioxidant defenses are lowered during pregnancy as indicated by lowered PON1 (Rojekar and Mogarekar, 2015), TRAP (Salas-Pacheco et al, 2016), -SH (De Lucca et al, 2016) and zinc (Ma et al, 2015;Nossier et al, 2015;Tabrizi and Pakdel, 2014) levels as well as other antioxidants (Salas-Pacheco et al, 2016). Increased peripheral inflammation and O & NS have been demonstrated to be associated with various obstetric complications, including preeclampsia (Kirbas et al, 2016;Ma et al, 2015;Nossier et al, 2015), glucose intolerance (Zein et al, 2016), miscarriage, fetal anomaly and growth restriction and preterm labor (Duhig et al, 2016;Mukhopadhyay et al, 2015).…”